Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

IMAX vs CNVS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

IMAX Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 9–1 Matrix Metrics)

IMAX Overall Winner 6-Pillar Tally: IMAX 5 – 1 CNVS Matrix Metrics: IMAX 9 – 1 CNVS

As of Nov 20, 2026, Imax Corp (IMAX) is the stronger overall head-to-head candidate over Cineverse Corp. (CNVS) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). IMAX carries a Unified Composite Score of 62.2/100 (BUY) at $46.13 (20.3x Forward P/E, 30.5% operating margin), whereas CNVS carries 35.9/100 (SELL) at $1.73 (38.8x Forward P/E, -12.0% operating margin).

  • Growth vs. Quality Trade-Off: IMAX earns the overall head-to-head edge with a stronger Unified Composite Score (62.2/100 BUY vs. CNVS 35.9/100 SELL) and 0.36β · 36% Vol risk profile, whereas CNVS leads top-line expansion (+110.0% YoY revenue growth, 0.46x PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: IMAX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.1); meanwhile CNVS trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 46.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About IMAX vs CNVS
IMAX NYSE Head-to-Head Winner
Imax Corp
Photographic Equipment & Supplies
$46.13
-0.11% 1D
Market Cap $2.5B
TTM Revenue $484M
Forward P/E 20.3x
Beta / 30D Vol 0.36β · 36% Vol
Unified Composite Score
62.2 / 100 BUY
Tech 76.0 Fund 68.0 Flow 64.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -2.4%), weak momentum, RSI 34
RSI-14: 34.1 · SMA20: $49.03 · SMA50: $51.30
CNVS NASDAQ
Cineverse Corp. Class A Common Stock
Services-Video Tape Rental
$1.73
-5.46% 1D
Market Cap $49.1M
TTM Revenue $99M
Forward P/E 38.8x
Beta / 30D Vol 1.19β · 110% Vol
Unified Composite Score
35.9 / 100 SELL
Tech 15.0 Fund 36.0 Flow 54.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 47
RSI-14: 46.9 · SMA20: $1.70 · SMA50: $1.82

6-Pillar Scorecard Institutional Category Breakdown (IMAX 5 – 1 CNVS)

Columns: Metric · IMAX · CNVS
1. Valuation Multiples IMAX
Forward P/E 20.3x 38.8x
Trailing P/E 19.6x 38.8x
PEG Ratio 1.05x 0.46x
EV / Revenue 5.3x 0.7x
2. Growth & Scale IMAX
Revenue Growth (YoY) +63.7% +110.0%
Earnings Growth (YoY) +429.7% +21.1%
TTM Revenue (USD) $484M $99M
Market Cap $2.5B $49.1M
3. Profitability & Quality IMAX
Gross Margin 63.6% 42.7%
Operating Margin 30.5% -12.0%
Net Profit Margin 27.7% -2.1%
Return on Equity (ROE) 27.6% -4.6%
4. Balance Sheet & Cash Flow IMAX
Cash Generation (TTM) $192M EBITDA -$18M
Cash Flow Margin 39.7% EBITDA Mgn -17.9%
Net Cash / Leverage $36M Net Debt (0.50x D/E) $22M Net Debt (0.65x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning IMAX
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 41.8% (5th %ile) 131.8% (28th %ile)
Put/Call OI Skew 3.04x (Put-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat CNVS
OpEx & R&D Intensity 33.1% of Rev ($160M) 54.7% of Rev ($54M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Entertainment Operator Entertainment Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: IMAX (9) vs CNVS (1)
Institutional Metric IMAX CNVS Criterion Row Edge
Market Capitalization
Scale
$2.5B $49.1M Larger Scale IMAX
Trailing P/E Ratio
Valuation
19.6x 38.8x Lower Multiple IMAX
Forward P/E Ratio
Valuation
20.3x 38.8x Lower Multiple IMAX
Revenue Growth (YoY)
Growth
+63.7% +110.0% Higher Growth CNVS
Operating Margin (TTM)
Profitability
30.5% -12.0% Higher Margin IMAX
Net Profit Margin
Profitability
27.7% -2.1% Higher Margin IMAX
Return on Equity (ROE)
Capital Efficiency
27.6% -4.6% Higher ROE IMAX
52-Week Range Position
Momentum
54% ($33–$58) 16% ($1–$3) Stronger Trend IMAX
Beta / 30D Volatility
Risk Regime
0.36β · 36% Vol 1.19β · 110% Vol Lower Realized Risk IMAX
Unified Institutional Score
Composite Signal
62.2 / 100 (BUY) 35.9 / 100 (SELL) Higher Composite IMAX
Trailing 12M Revenue (USD)
Operating Scale
$484M $99M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
63.6% 42.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.05x PEG · 5.3x EV/Rev 0.46x PEG · 0.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$192M EBITDA ($36M Net Debt (0.50x D/E)) -$18M ($22M Net Debt (0.65x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CNVS +24.15 pp
IMAX: -11.81% · CNVS: +12.34%
3M Horizon IMAX +16.08 pp
IMAX: -15.81% · CNVS: -31.89%
6M Horizon IMAX +47.31 pp
IMAX: +17.92% · CNVS: -29.39%
1Y Horizon IMAX +59.01 pp
IMAX: +26.59% · CNVS: -32.42%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period IMAX Revenue CNVS Revenue IMAX Op. Margin CNVS Op. Margin Margin Leader
FY2019 $400M $50M 19.5% -10.5% IMAX
FY2020 $140M $0M -88.9% -310.6% IMAX
FY2021 $250M $0M 4.3% -2245.5% IMAX
FY2022 $300M $60M -1.6% -1.7% IMAX
FY2023 $370M $70M 13.4% -13.1% IMAX
FY2024 $350M $50M 12.5% -32.0% IMAX
FY2025 $410M $80M 20.5% 10.1% IMAX
FY2026 N/A $70M N/A -23.1% CNVS

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
IMAX CONSOLIDATION
70d in phase · OBV DISTRIBUTION
Current IV 41.8%
IV Percentile 5th %ile
Put/Call OI Skew 3.04x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow DISTRIBUTION
Exact IMAX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CNVS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 131.8%
IV Percentile 28th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow NEUTRAL
Exact CNVS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
IMAX Moat Profile High-Margin Pricing Power Moat
Entertainment Operator
Competes within the Entertainment value chain with $2.5B market capitalization and 30.5% operating margin.
OpEx & R&D Reinvestment 33.1% of Rev ($160M)
90D Engineering Disclosures 0 Published
CNVS Moat Profile Cyclical / Execution-Driven Positioning
Entertainment Operator
Competes within the Entertainment value chain with $49.1M market capitalization and -12.0% operating margin.
OpEx & R&D Reinvestment 54.7% of Rev ($54M)
90D Engineering Disclosures 0 Published

Investor FAQ IMAX vs CNVS Key Questions & Quantitative Answers

As of Nov 20, 2026, Imax Corp (IMAX) is the stronger overall head-to-head candidate over Cineverse Corp. (CNVS) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). IMAX carries a Unified Composite Score of 62.2/100 (BUY) at $46.13 (20.3x Forward P/E, 30.5% operating margin), whereas CNVS carries 35.9/100 (SELL) at $1.73 (38.8x Forward P/E, -12.0% operating margin). Growth vs. Quality Trade-Off: IMAX earns the overall head-to-head edge with a stronger Unified Composite Score (62.2/100 BUY vs. CNVS 35.9/100 SELL) and 0.36β · 36% Vol risk profile, whereas CNVS leads top-line expansion (+110.0% YoY revenue growth, 0.46x PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: IMAX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.1); meanwhile CNVS trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 46.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

IMAX leads the Growth & Scale pillar: IMAX posts +63.7% YoY revenue growth and +429.7% YoY earnings growth on $484M TTM revenue (63.6% gross margin, 30.5% operating margin), compared with CNVS at +110.0% YoY revenue growth and +21.1% YoY earnings growth on $99M TTM revenue (42.7% gross margin, -12.0% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), IMAX cumulative revenue shifted +2.5% while CNVS shifted +40.0%. In operating R&D and SG&A reinvestment, IMAX deploys 33.1% of Rev ($160M) (0 90-day corporate R&D disclosures) versus 54.7% of Rev ($54M) (0 disclosures) for CNVS.

IMAX screens cheaper on headline valuation multiples. IMAX trades at 20.3x Forward P/E, 19.6x Trailing P/E, 1.05x PEG, and 5.3x EV/Revenue (39.7% EBITDA margin), whereas CNVS trades at 38.8x Forward P/E, 38.8x Trailing P/E, 0.46x PEG, and 0.7x EV/Revenue (-17.9% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against IMAX (27.6% ROE) versus CNVS (-4.6% ROE) capital efficiency.

In options market volatility and institutional positioning, IMAX carries 41.8% implied volatility (5th %ile, Compressed (<25th %ile)), a 3.04x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.36β · 36% Vol realized risk). By comparison, CNVS carries 131.8% implied volatility (28th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.19β · 110% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.